BGI Genomics Co Ltd (300676) — Cash Flow Quality Index
BGI Genomics Co Ltd (300676) has a Cash Flow Quality Index of -0.29x as of June 2025. Operating cash flow of CN¥-16.74 Million is below net income of CN¥58.47 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore investment intensity of BGI Genomics Co Ltd to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
BGI Genomics Co Ltd Cash Flow Quality Index (2012–2023)
Historical Cash Flow Quality Index for BGI Genomics Co Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 300676 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for BGI Genomics Co Ltd (2012–2023)
Year-by-year earnings quality comparison for BGI Genomics Co Ltd. For live market cap and the full company financial profile, see 300676 company net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 4.40x | CN¥408.77 Million | CN¥92.90 Million | ▲ +2598.8% |
| 2022 | 0.16x | CN¥130.88 Million | CN¥802.77 Million | ▼ -90.4% |
| 2021 | 1.69x | CN¥2.48 Billion | CN¥1.46 Billion | ▼ -1.1% |
| 2020 | 1.71x | CN¥3.60 Billion | CN¥2.10 Billion | ▲ +111.2% |
| 2019 | 0.81x | CN¥224.25 Million | CN¥276.33 Million | ▲ +2036.4% |
| 2018 | 0.04x | CN¥14.69 Million | CN¥386.65 Million | ▼ -93.8% |
| 2017 | 0.61x | CN¥243.66 Million | CN¥398.09 Million | ▼ -13.0% |
| 2016 | 0.70x | CN¥234.07 Million | CN¥332.69 Million | ▼ -43.9% |
| 2015 | 1.25x | CN¥328.68 Million | CN¥262.10 Million | ▲ +999.0% |
| 2014 | -0.14x | CN¥-8.16 Million | CN¥58.53 Million | ▼ -165.6% |
| 2013 | 0.21x | CN¥36.70 Million | CN¥172.67 Million | ▼ -75.0% |
| 2012 | 0.85x | CN¥72.49 Million | CN¥85.35 Million | — |